These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 28391624)

  • 1. Nitric oxide in the pathophysiology of retinopathy: evidences from preclinical and clinical researches.
    Opatrilova R; Kubatka P; Caprnda M; Büsselberg D; Krasnik V; Vesely P; Saxena S; Ruia S; Mozos I; Rodrigo L; Kruzliak P; Dos Santos KG
    Acta Ophthalmol; 2018 May; 96(3):222-231. PubMed ID: 28391624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of nitric oxide, superoxide, peroxynitrite and PARP in diabetic retinopathy.
    Zheng L; Kern TS
    Front Biosci (Landmark Ed); 2009 Jan; 14(10):3974-87. PubMed ID: 19273327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aqueous Humour and Serum Levels of Nitric Oxide, Malondialdehyde and Total Antioxidant Status in Patients with Type 2 Diabetes with Proliferative Diabetic Retinopathy and Nondiabetic Senile Cataracts.
    Kulaksızoglu S; Karalezli A
    Can J Diabetes; 2016 Apr; 40(2):115-9. PubMed ID: 26388409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inverse relationship between the intraretinal concentration of bioavailable nitric oxide and blood glucose in early experimental diabetic retinopathy.
    Guthrie MJ; Osswald CR; Kang-Mieler JJ
    Invest Ophthalmol Vis Sci; 2014 Dec; 56(1):37-44. PubMed ID: 25503458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant utilization of nitric oxide and regulation of soluble guanylate cyclase in rat diabetic retinopathy.
    Schaefer S; Kajimura M; Tsuyama S; Uchida K; Sato E; Inoue M; Suematsu M; Watanabe K
    Antioxid Redox Signal; 2003 Aug; 5(4):457-65. PubMed ID: 13678534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. S-nitrosoglutathione inhibits inducible nitric oxide synthase upregulation by redox posttranslational modification in experimental diabetic retinopathy.
    Rosales MA; Silva KC; Duarte DA; de Oliveira MG; de Souza GF; Catharino RR; Ferreira MS; Lopes de Faria JB; Lopes de Faria JM
    Invest Ophthalmol Vis Sci; 2014 May; 55(5):2921-32. PubMed ID: 24699383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of diabetic retinopathy with angiopoietin-1.
    Joussen AM; Poulaki V; Tsujikawa A; Qin W; Qaum T; Xu Q; Moromizato Y; Bursell SE; Wiegand SJ; Rudge J; Ioffe E; Yancopoulos GD; Adamis AP
    Am J Pathol; 2002 May; 160(5):1683-93. PubMed ID: 12000720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nitrosative Stress and Its Association with Cardiometabolic Disorders.
    Pérez-Torres I; Manzano-Pech L; Rubio-Ruíz ME; Soto ME; Guarner-Lans V
    Molecules; 2020 May; 25(11):. PubMed ID: 32486343
    [No Abstract]   [Full Text] [Related]  

  • 9. Diabetic retinopathy--biomolecules and multiple pathophysiology.
    Ahsan H
    Diabetes Metab Syndr; 2015; 9(1):51-4. PubMed ID: 25450817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of interleukin-1beta in the development of retinopathy in rats: effect of antioxidants.
    Kowluru RA; Odenbach S
    Invest Ophthalmol Vis Sci; 2004 Nov; 45(11):4161-6. PubMed ID: 15505070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The retina: oxidative stress and diabetes.
    van Reyk DM; Gillies MC; Davies MJ
    Redox Rep; 2003; 8(4):187-92. PubMed ID: 14599341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms involved in the development of diabetic retinopathy induced by oxidative stress.
    Guzman DC; Olguín HJ; García EH; Peraza AV; de la Cruz DZ; Soto MP
    Redox Rep; 2017 Jan; 22(1):10-16. PubMed ID: 27420399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antioxidants and diabetic retinopathy.
    Williams M; Hogg RE; Chakravarthy U
    Curr Diab Rep; 2013 Aug; 13(4):481-7. PubMed ID: 23649947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between miRNAs expression and signaling pathways of oxidative stress in diabetic retinopathy.
    Satari M; Aghadavod E; Mobini M; Asemi Z
    J Cell Physiol; 2019 Jun; 234(6):8522-8532. PubMed ID: 30478922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Up-regulated expression of neuronal nitric oxide synthase in experimental diabetic retina.
    Park JW; Park SJ; Park SH; Kim KY; Chung JW; Chun MH; Oh SJ
    Neurobiol Dis; 2006 Jan; 21(1):43-9. PubMed ID: 16023354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxidative stress and diabetic retinopathy.
    Kowluru RA; Chan PS
    Exp Diabetes Res; 2007; 2007():43603. PubMed ID: 17641741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ascorbic acid repletion: A possible therapy for diabetic macular edema?
    May JM
    Free Radic Biol Med; 2016 May; 94():47-54. PubMed ID: 26898503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antioxidant enzymes and diabetic retinopathy.
    Yildirim Z; Uçgun NI; Kiliç N; Gürsel E; Sepici-Dinçel A
    Ann N Y Acad Sci; 2007 Apr; 1100():199-206. PubMed ID: 17460179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. L-Arginine-nitric oxide pathway-related metabolites in the aqueous humor of diabetic patients.
    Hattenbach LO; Allers A; Klais C; Koch F; Hecker M
    Invest Ophthalmol Vis Sci; 2000 Jan; 41(1):213-7. PubMed ID: 10634623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beyond AREDS: is there a place for antioxidant therapy in the prevention/treatment of eye disease?
    Kowluru RA; Zhong Q
    Invest Ophthalmol Vis Sci; 2011 Nov; 52(12):8665-71. PubMed ID: 22065212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.